About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Boston | 21,610 Studies Near You

Clinical TrialsBoston

Clinical Trials in Boston

Discover 21,610 clinical trials near Boston, Massachusetts. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 21,610 trials

TerminatedStudy to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) PatientsRociletinib is a novel, potent, small molecule irreversible tyrosine kinase inhibitor (TKI) that selectively targets mutant forms of the epidermal growth factor receptor (EGFR)…NCT01526928·Duarte, California and 48 others

Find Trials by Condition in Boston

Breast Cancerin Boston Lung Cancerin Boston Prostate Cancerin Boston Colorectal Cancerin Boston Melanomain Boston Leukemiain Boston Lymphomain Boston Pancreatic Cancerin Boston Ovarian Cancerin Boston Brain Cancerin Boston Diabetesin Boston

Data from ClinicalTrials.govTerms

CompletedA Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular AlterationsPhase 1 and 2 trial to study the safety, pharmacokinetics, pharmacodynamics, patient reported outcomes and efficacy of PF-06463922 in ALK + advanced non-small cell lung cancer…NCT01970865·Fayetteville, Arkansas and 76 others

CompletedApremilast 30 mg Twice Daily (BID) Combined With DupilumabOpen label phase 2 investigational study of efficacy and safety of apremilast 30 mg twice a day (BID) in chronic atopic dermatitis when added to the FDA approved treatment…NCT04306965·Boston, Massachusetts

CompletedIntravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)This study was conducted in two parts; Part A and Part B: Part B was initially planned to include two cohorts.NCT01527500·Phoenix, Arizona and 18 others

CompletedReducing Risk After an Adverse Pregnancy OutcomeThis application to the Boston University Medical Center Institutional Review Board outlines a research plan devoted to identifying and managing maternal depression in Early…NCT01182363·Boston, Massachusetts and 3 others

CompletedUreteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled TrialThe rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not…NCT03855787·Los Angeles, California and 6 others

CompletedInternet-Based Depression Screening for College StudentsThis study aims to determine whether using telecommunication tools, specifically web pages containing online screening instruments and real-time video chat, will be an efficient…NCT01326793·Boston, Massachusetts

Not yet recruitingSuzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip FractureThe goal of this clinical trial is to learn whether suzetrigine (Journavx®), when added to standard multimodal pain management, can reduce opioid use while providing adequate pain…NCT07905404·Boston, Massachusetts

CompletedPre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides DifficileClostridioides difficile (C. difficile) is the most common healthcare-associated pathogen, causing \>500,000 infections and \>29,000 deaths per year in the US.NCT05389904·Boston, Massachusetts

CompletedObinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell TransplantationThis research study is studying a drug called obinutuzumab as a means of preventing chronic Graft vs. Host Disease (cGVHD).NCT02867384·Palo Alto, California and 4 others

CompletedGeneralized Anxiety Therapy EffectivenessThis study will examine the effectiveness of digital CBT versus psychoeducation in improving anxiety for those with Generalized Anxiety Disorder.NCT05748652·Boston, Massachusetts

CompletedEvaluation of WIRION™ EPS in Lower Extremities ArteriesDemonstrate the safety and performance of the WIRION™ EPS in subjects undergoing lower extremity atherectomy for the treatment of Peripheral Arterial Disease (PAD)NCT02780349·Denver, Colorado and 9 others

CompletedLedipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV InfectionThis study is to evaluate the antiviral efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) in adults with nosocomial genotype 1…NCT01924949·Boston, Massachusetts

CompletedFood Talk: A New App for Daily Food MonitoringThis project will pilot test a new app for self-monitoring food intake using natural spoken language (by voice recognition or text) to provide daily estimates of energy and…NCT03869658·Boston, Massachusetts

Active not recruitingA Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of TherapiesThe purpose of this study is to evaluate the therapeutic efficacy, safety and tolerability of ianalumab in adult patients with primary ITP previously treated with at least one…NCT05885555·Boston, Massachusetts and 23 others

Active not recruitingHALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman SyndromeThe purpose of this study is to evaluate the safety and tolerability of ascending doses of ION582 administered intrathecally in participants with Angelman syndrome.NCT05127226·San Diego, California and 10 others

UnknownKRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor TreatmentThis study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with myelofibrosis (MF) who no longer benefit from treatment with a JAK…NCT03662126·Birmingham, Alabama and 190 others

CompletedImpact of Smoking and Its Cessation on Systemic and Airway Immune ActivationThe purpose of this study is to learn how smoking affects the immune systems in people with HIV infection.NCT02836067·Boston, Massachusetts

TerminatedA Trial of ALB 109564(a) in Subjects With Advanced Solid TumorsThe purpose of this study is to determine the maximum tolerated dose of ALB 109564(a), a novel tubulin inhibitor, and to assess safety, pharmacokinetics, and anti-tumor activity…NCT00724100·Boston, Massachusetts and 1 other

CompletedProspective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine HeadachesAccording to the peripheral trigger theory of migraine headaches, nociceptive inputs from irritated or compressed cranial nerve branches can lead to neurovascular changes in the…NCT02351544·San Francisco, California and 5 others

Page 1 of 1081Next

Heart Diseasein Boston